China Top 10 Freeze Rabies Prophylaxis Vaccine Potential Enterprises

July 10, 2024

A pharmaceutical company has developed a groundbreaking rabies prophylaxis vaccine that can be stored at freezing temperatures, eliminating the need for costly cold chain logistics. This innovation is set to revolutionize the distribution of rabies vaccines in remote and resource-limited areas, saving countless lives worldwide.

Chengdu Institute of Biological Products Co., Ltd.
Changchun Zhuoyi Biological Co., Ltd
Changchun BCHT Biotechnology Co., Ltd.

Chengdu Institute of Biological Products Co., Ltd.

Establishment time : 1967

website : http://www.cdibp.com.cn/

Main Product : Vaccines, biological products

Company Profile

Chengdu Institute of Biological Products Co., Ltd. is a leading biopharmaceutical company in China, specializing in the research, development, and production of vaccines and biological products. With over 50 years of experience, the company has established a strong presence in both domestic and international markets, offering a wide range of high-quality products to meet the healthcare needs of people worldwide.

Changchun Zhuoyi Biological Co., Ltd

Establishment time : 2005

website : www1.zhuoyi-bio.com

Main Product : Human Rabies Vaccine,Rabies Prevention ,Freeze-dried Human Rabies Vaccine ,Rabies Vaccine,Human Rabies Vaccination,Human Rabies Vaccine and Infant

Company Profile

Changchun Zhuoyi Biological Co., Ltd., located in Shuangyang Economic Development Zone of Changchun City, is a key vaccine manufacturer invested by Zhejiang SelCorning Biotechnology Co., Ltd. in Jilin Province, and a vice chairman unit of Zhejiang Chamber of Commerce in Jilin Province. The company was founded on January 27, 2005. Mr. Feng Xingfu, chairman and general manager of the company, graduated from the Department of Biology, University of Science and Technology of China, and has been engaged in the marketing and enterprise management of biological products since the 1980s. The company has a registered capital of one hundred and one million six hundred and ninety-two thousand seven hundred and eighty-four yuan, covers an area of 41600 square meters, and has the leading vaccine research and development and production capacity in China. Changchun Zhuoyi Biological Co., Ltd. is a new vaccine manufacturer integrating R&D, production and sales. At present, the biological products approved by the company are mainly Rabies Vaccine (Vero cell) for Human Use, Freeze-dried. The company successfully passed the two in one inspection at the end of 2016 and obtained the registration approval and GMP certificate, which was officially put into production in January 2017. The company's existing production workshop covers an area of about 5700 square meters, with a cumulative investment of 400 million yuan. At present, the maximum annual output is 1 million people. The second phase workshop has been completed at the end of 2018, and will be officially produced in 2020. By then, the production capacity can reach 4 million people. The company has nearly 2000 square meters of pilot scale research workshop, advanced equipment such as bioreactor, ultrafiltration system, AKTA purification workstation, fluorescence microscope, etc., which are used for virus culture, improvement of purification system and identification of recombinant protein. The company has maintained close scientific research cooperation with many scientific research institutions at home and abroad. At present, the company is developing a serum rabies vaccine and a broad-spectrum human papillomavirus vaccine jointly developed with the Institute of Basic Medicine of the Chinese Academy of Medical Sciences. It is planned to cooperate with Murdoch Children's Research Institute in Australia to develop the round vaccine project. At the same time, the company also actively explores the path of internationalization. At present, the company has started to register in the Philippines, Pakistan, Cambodia, Bangladesh, Mongolia, Uzbekistan and other countries. It is estimated that the export of finished products in some markets will be realized by 2020. The company's technical cooperation project with Australia is one of the company's many international cooperation projects. The company always adheres to the concept of "standardized management, quality first", and adheres to the core values of "honesty, diligence, innovation, preciseness, learning and happiness", so as to provide high-quality vaccine products to serve the health of the people.

Changchun BCHT Biotechnology Co., Ltd.

Establishment time : Changchun BCHT Biotechnology Co., Ltd. was founded in 2005.

website :

Main Product : With a medium-sized workforce, BCHT has established itself as a key player in the biotechnology industry.

Company Profile

For more information, visit their website at http://www.bchtbio.com/.

Author:

Mr. Simba Li

E-mail:

lixuejian@zy-bio.cn

Phone/WhatsApp:

+86 18946525326